LEAWOOD, Kan., April 22, 2019 /PRNewswire/ -- Aratana
Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company
focused on the development and commercialization of innovative
therapeutics for dogs and cats, will host a live conference call on
Wednesday, May 8 at 4:30 p.m. ET to discuss financial results from
the first quarter ended March 31,
2019.
Interested participants and investors may access the audio
webcast or use the conference call dial-in:
1 (866) 364-3820 (U.S.)
1 (855) 669-9657 (Canada)
1 (412) 902-4210 (International)
A replay of the first quarter 2019 results teleconference will
be available the same day of the event and an audio webcast will be
accessible for 90 days in the Aratana Investor Room. For a replay
of the call, use the below dial-in and conference ID 10131046:
1 (877) 344-7529 (U.S.)
1 (855) 669-9658 (Canada)
1 (412) 317-0088 (International)
About Aratana Therapeutics
Aratana Therapeutics is a
pet therapeutics company focused on developing and commercializing
innovative therapeutics for dogs and cats. Our mission is to
successfully develop and deliver best-in-class therapeutics,
provide comprehensive service to veterinarians and serve as a
collaborator of choice for human and animal health companies. We
believe our therapeutics are highly differentiated, resolve
recognizable needs in compelling markets and have therapeutic
profiles superior to the standard of care. For more information,
please visit www.aratana.com.
Contacts
For investor inquires:
Rhonda Hellums
ir@aratana.com
(913) 353-1026
For media inquiries:
Rachel Reiff
media@aratana.com
(913) 353-1050
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aratana-therapeutics-to-report-first-quarter-2019-financial-results-300835211.html
SOURCE Aratana Therapeutics, Inc.